Reprogrammed Interchange LLC Reduces Stake in Vor Biopharma Inc.

Reprogrammed Interchange LLC, along with Reid Hoffman, filed Amendment No. 8 to Schedule 13D, reporting a reduction in their stake in Vor Biopharma Inc. The amendment details multiple open market transactions from October 15, 2025, through October 16, 2025, where Reprogrammed Interchange LLC sold shares of Vor Biopharma Inc. This resulted in a decrease in the number of shares beneficially owned by the reporting persons by more than one percent of the outstanding shares. The total shares sold during this period were 73,676, with weighted average per share sale prices of $31.9196 and $30.4548. The reporting persons now hold 17.6% of the outstanding shares of Vor Biopharma Inc.